by Jordana Choucair | Jul 28, 2022 | Opioid/Substance Use Disorders
Allergan, a subsidiary of AbbVie, agreed to a $2 billion settlement with state and local governments to end thousands of lawsuits related to the marketing of its opioid Kadian. A federal court in Cleveland is working out details, such as the payout period and what...
by Jordana Choucair | Jul 28, 2022 | Payers
The Centers for Medicare & Medicaid Services (CMS) released its annual Inpatient Rehabilitation Facility Prospective Payment System final rule, increasing payments for inpatient rehabilitation facilities by 3.9 percent in 2023. CMS estimates that total payments...
by Jordana Choucair | Jul 28, 2022 | Payers
CMS launched its Maternity Care Action Plan to support the Biden administration’s push address the nation’s maternal health crisis. The plan aims to “improve health outcomes and reduce inequities for people during pregnancy, childbirth and the...
by Jordana Choucair | Jul 27, 2022 | Access & Coverage
The Biden administration approved three more states’ plans to extend postpartum Medicaid coverage to women up to one year after pregnancy. Kansas, Connecticut, and Massachusetts join 15 other states and the District of Columbia in extending coverage for people...
by Jordana Choucair | Jul 27, 2022 | Health IT
The House Rules Committee advanced legislation that would extend major flexibilities for telehealth reimbursement through 2024. The Advancing Telehealth Beyond COVID-19 Act would ensure waivers to telehealth regulations for originating site and geographic requirements...
by Jordana Choucair | Jul 27, 2022 | Opioid/Substance Use Disorders
Teva Pharmaceuticals reached a tentative $4.25 billion settlement with states and localities over its role in the opioid addiction crisis. The deal requires Teva to make payments to approximately 2,500 local governments, states, and tribes over the course of 13 years....
Recent Comments